Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Hoelzer
D
D
Thiel
E
E
Löffler
H
H
Büchner
T
T
Ganser
A
A
Heil
G
G
Kurrle
E
E
Heimpel
H
H
Koch
P
P
Lipp
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008875:Middle Aged; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011379:Prognosis; D013713:Teniposide / Q000008:administration & dosage*
D003561:Cytarabine; D013713:Teniposide; D011034:Podophyllotoxin